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Abstract
Mycobacterium tuberculosis (Mtb)mutants lacking rv1411c, which encodes the lipoprotein
LprG, and rv1410c, which encodes a putative efflux pump, are dramatically attenuated for
growth in mice. Here we show that loss of LprG-Rv1410 inMtb leads to intracellular triacyl-
glyceride (TAG) accumulation, and overexpression of the locus increases the levels of TAG
in the culture medium, demonstrating a role of this locus in TAG transport. LprG binds TAG
within a large hydrophobic cleft and is sufficient to transfer TAG from donor to acceptor
membranes. Further, LprG-Rv1410 is critical for broadly regulating bacterial growth and
metabolism in vitro during carbon restriction and in vivo during infection of mice. The growth
defect in mice is due to disrupted bacterial metabolism and occurs independently of key
immune regulators. The in vivo essentiality of this locus suggests that this export system
and other regulators of metabolism should be considered as targets for novel therapeutics.
Author Summary
Of the estimated 2 billion people worldwide currently infected withMycobacterium tuber-
culosis (Mtb), surprisingly few go on to develop active tuberculosis (TB) disease. The vast
majority, 95 percent, of infected individuals develop latent TB, remaining infected but
without disease. Despite its importance in global health, the question of what determines
whether an infected individual will develop active or latent TB remains largely unan-
swered. Changes in howMtb grows in response to stressors presented by the host
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environment likely play an important role in this process. In particular, the manifold ways
in whichMtb synthesizes, degrades, and transports lipids dictates its growth in an infected
host. Here, we show that lipid transport is an important function of two TB genes known
to be required forMtb’s ability to cause disease in the mouse model of infection. Using a
variety of genetic and biochemical techniques, we found that the products of these genes
prevent the cytosolic accumulation of a lipid associated with non-growingMtb under the
metabolic conditions it encounters during infection. Our results indicate an important
role for the metabolism ofMtb in its ability to orchestrate a productive infection and cause
disease.
Introduction
Tuberculosis continues to be a major global health threat.Mycobacterium tuberculosis (Mtb) is
estimated to infect 2 billion people worldwide, or one-third of the world’s population [1].
Despite its clinical importance, key aspects of tuberculosis (TB) pathogenesis are still not
understood, including predictors of whether exposure will lead to active versus latent disease.
Only 5% of exposed individuals will go on to develop active disease, whereas the remaining
95% will develop latent disease but remain susceptible to reactivation [2]. Therefore,Mtb is
able to survive during periods of reduced growth and has the capacity to regrow rapidly.
How does this happen?Mtb orchestrates growth arrest in response to stresses encountered
in the host, and lipid metabolism, a central part ofMtb’s life inside the host, likely plays an inte-
gral role [3,4]. While the synthesis and degradation of lipids has been extensively studied, their
transport is far less well understood. We have previously identified two genes, rv1411c and
rv1410c, that form an operon and are conditionally essential for survival in the mouse [5,6].
Rv1411c encodes the mycobacterial lipoprotein LprG, which can bind triacylated phospholip-
ids such as phosphatidylinositol mannoside (PIM) and lipoarabinomannan (LAM) [7] and is
necessary for normal surface display of LAM [8,9]. However, unlike other known mycobacte-
rial lipoproteins, LprG is in an operon with a putative integral membrane transporter, Rv1410,
a member of the major facilitator superfamily (MFS) [10,11]. Both genes are required inM.
smegmatis for normal cell wall composition and for efflux of toxins such as ethidium bromide
[12]. LprG has structural homology to the mycobacterial lipoprotein LppX, which, along with
the transporter MmpL7, is required for the outer membrane localization of phthiocerol dimy-
cocerosate (PDIM), a virulence-associated lipid [13,14]. By analogy, LprG and Rv1410 might
function together to position mycobacterial lipids in the cell wall.
LprG binds to PIM and LAM, two TLR2 agonists, and is predicted to transport these two
lipids to the cell surface ofMtb [7]. Deletion of LprG limits TLR2 activation and blocks certain
aspects of phagolysosomal fusion [7,8] but it is unclear whether these effects account for the
strong in vivo growth attenuation of LprG-deficient bacteria. Loss of TLR2 does not alter
growth ofMtb in vivo [15] and loss of key components of the TLR-induced signaling cascade,
such as MyD88, actually worsen infection due to effects of IFN-γ-mediated activation of mac-
rophages [16,17]. Thus, mislocalization of two TLR2 agonists, PIM and LAM, would not be
expected to cause the significant in vivo attenuation observed upon loss of LprG function.
Given that LprG binds several classes ofMtb lipids, at least in vitro, we instead posited that the
distribution of other lipids withinMtb is affected by the loss of LprG and Rv1410.
To investigate this possibility, we used unbiased lipidomic analysis to examine the abun-
dance and distribution of lipids inMtb. We found that disruption of LprG-Rv1410 function
leads to an increased level of intracellular TAG. Furthermore, LprG co-crystallizes with TAG
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and transports TAG between lipid membranes in vitro, implying that these proteins are
required to transport TAG out of the cytoplasm. This conclusion is supported by data showing
that overexpression of LprG-Rv1410 increases release of TAG into the culture medium of
broth-grownMtb. Finally, loss of LprG-Rv1410 function is associated withMtb growth attenu-
ation both in vitro during carbon restriction and in vivo. Thus, we identify LprG as a physiolog-
ically important TAG transporter. This previously unknown mechanism likely explains the
surprising presence of recently discovered TAG in the outer membrane ofMycobacterium
smegmatis [18]. Further, because TAG plays an essential role inMtbmetabolism [19,20], we
propose that an altered metabolic state is likely ultimately responsible for the significantly
reduced survival and virulence of LprG-Rv1410 mutants in the host.
Results
Loss of LprG-Rv1410 leads to triacylglyceride accumulation inMtb
Our previous studies suggested that LprG and Rv1410 act together in processes that affect cell
wall integrity [12]. Thus, we hypothesized that mutations that disrupted one or both genes
would have similar phenotypes. We used two different strains: anMtbH37Rv strain with a
transposon insertion in rv1410c (rv1410c::Tn; Mut1) [5] and a strain from which we deleted
both genes by allelic exchange (ΔlprG-rv1410c, Mut2) (Fig 1A and S1 Fig and S1 Methods). To
analyze lipids produced by each strain, we performed comparative lipidomic analyses [21].
Briefly, we extracted cell-associated lipids fromMtb during stationary growth phase and ana-
lyzed the total lipid content by normal phase high performance liquid chromatography-mass
spectrometry (HPLC-MS). We performed initial analyses in both positive and negative ion
modes, but, because we found fewer reproducible lipid alterations in negative mode, we focused
further experiments on positive mode analysis. We conducted all experiments in biological
triplicate and assigned ions appearing in two or more analyses with nearly identical mass-to-
charge ratio (m/z) and retention time as ‘molecular events.’ By generating mass spectrometry
intensity ratios for many thousands of paired events from wild-type and genetically altered
mycobacteria, this method provides organism-wide descriptions of lipid change and is capable
of identifying individual changed lipids.
For analysis, we aligned all events with equivalent mass and retention time across datasets
to enable detection of changed events, which are defined as having an intensity value altered by
2-fold with a corrected p value< 0.05. Among 7487 total events detected, 309 (4.1%) met these
criteria. Previous analyses estimate the rate of false positive changed lipids as being less than
one percent [21]. The percentage of changed events detected here (4.1%) is above method-spe-
cific variance and similar to the percent change detected between theMtb strains H37Rv and
W Beijing [21]. The absolute number of changed events exceeded our ability to identify them,
so we used previously validated criteria to group and prioritize events for molecular identifica-
tion [22,23]. In ranking events of known mass but unknown chemical identity, we prioritized
those with highest absolute fold-change and lowest p values. Further, in normal phase chroma-
tography, lipid classes are separated in time, but alkylforms within one class show nearly iden-
tical retention time with mass intervals characteristic of unsaturations (H2) or alkyl (CH2)
chain length variants. In this way, the large list of changed ions can be grouped into a smaller
number of lipid classes, even in the absence of knowing the chemical name of each lipid.
Within each class, the intensity values of each member can be individually assessed to see
whether they change with the same direction and magnitude after mutation. Therefore, as a
third criterion for highlighting events of biological interest, we sought lipid classes that showed
parallel changes among all events corresponding to the alkylforms in a given lipid class.
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Combining these three criteria, we observed a striking pattern for 32 events that all belonged
to the same lipid class (Fig 1B, blue). These 32 events increased in intensity with similar
Fig 1. Lipidomics show that loss of LprG-Rv1410 results in triacylglyceride (TAG) accumulation inMtb. (A, left) Strains used in this study. (A, right)
Schematic showing predicted localization of proteins encoded by genes manipulated in this study. (B) Positive mode comparative lipidomics analysis from
stationary phaseM. tuberculosisMutant 2 (Mut2) and parental wild-type (WT) strains yielded 7487 total events (black and red) with 309 (red) that meet
change criteria of a two-fold increase in Mut2 compared to WT at a corrected p <0.05 (student’s paired t-test, Gene Pattern, Broad Institute). Each dot
represents the mean intensity over three biological replicates for a given molecular event in Mut2 compared to WT. For thirty-two of these them/z values
match the expected masses of TAG alkylforms (blue) detected as ammonium and hydrogen adducts. (C) Collision-induced dissociation mass spectrometry
of a representative TAG (TAG 58:0,m/z 564.93). (D-E) Mean intensity values for molecular events mapping to TAG isoforms (ammonium adducts) with the
indicated total number of carbons:unsaturations found in all alkyl chains in (D) WT, Mut1 and Mut2 and (E) WT, Mut2, and Complement (Comp2) strains.
Error bars showmean +/- SD. * p<0.05, ** p<0.01, ***p<0.001, in (D) Mut1 (†) or Mut2 (*) vs. WT and (E) WT (*) or Comp2 (†) vs. Mut2; 2-way ANOVA with
Bonferroni post-test correction.
doi:10.1371/journal.ppat.1005351.g001
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magnitude in the knockout strain and matched masses of TAG alkylforms in the MycoMass
database. Ion chromatograms showed that the events had the expected retention time of TAG
(3–4 min) as annotated in the MycoMap database [21]. The structures of TAG alkylforms with
a combined lipid length and saturation in the three chains of 48:0 (m/z 824.77), 58:0 (m/z
964.94), and 59:1 (m/z 976.93) corresponded to the expected total lipid lengths of mycobacte-
rial TAG. In order to formally rule the identity of an event as TAG, we performed collision
induced mass spectrometry (CID-MS) and detected the fragments of a protonated adduct of
C58 (Fig 1C) and other ions in the series (S2 Fig) as TAG having the expected mass intervals of
C16 and C26 fatty acyl units as well as the ions corresponding to the expected diacylglyceride
units (m/z 691.66,m/z 551.50).
Loss of Rv1410 function is sufficient for triacylglyceride accumulation
Because Rv1410 is a predicted integral membrane protein and LprG is a lipoprotein that is
shed into culture medium [24], we hypothesized that Rv1410 functions upstream of LprG in
regulating lipid transport across the plasma membrane. To validate this, and to control for
potential differences unlinked to the disrupted locus, we performed comparative lipidomics
analyses on Mut1 and Mut2 strains to assess the overlap in lipid perturbation phenotypes and
focused our analysis on lipids that increased in both mutant strains. By this more stringent
analysis, increases in TAG remained the major lipid alterations in both mutant strains. Individ-
ual TAG species with differing length (C56-62) and unsaturation (0–2) were detected at statis-
tically significantly elevated levels in both mutant versus wild-type strains across repeat
experiments as compared to other detected lipids (Fig 1D and S3 Fig). The absolute fold-
change in signals were large, more than 50-fold for most alkylforms, with increases in signal
intensity for TAG in Mut1 and Mut2 compared to WT ranging from 2- to 100-fold depending
on the TAG alkylform and strain evaluated. Upon complementation with a single copy of the
lprG-rv1410c operon (ΔlprG-rv1410c L5::lprG-rv1410c, Comp2), we detected reduced amounts
of TAG species compared to Mut2 for every alkylform (Fig 1E).
LprG binds to triacylglyceride
Previous studies have shown that the outer layers of the mycobacterial cell wall contain TAG
[25,26]. Further, as shown by reverse micelle extraction of mycobacterial surface lipids, TAG
represents a significant proportion of non-covalently associated lipids in the outer membrane
of mycobacteria [18]. Based on our lipidomics analysis, we hypothesized that LprG and
Rv1410 represent a formerly unknown mechanism to transport TAG from the cytoplasm to
the outer membrane. Previous work on the structure of LprG revealed a large central cavity
that can accommodate triacylated lipid species, including triacylated phosphatidylinositol
(Ac1PIM2) [7]. Based on a model in which Rv1410 transports TAG across the cytosolic mem-
brane and then transfers TAG to LprG in the cell wall, we hypothesized that LprG should bind
similarly to TAG. As predicted, co-crystallization with TAG (tripalmitoylglyceride, TAG 48:0)
revealed that the complex (Fig 2A) contains TAG, which is seated similarly to Ac1PIM2 in the
LprG binding site (PDB, 4ZRA). Briefly, the alpha-beta fold is maintained and consists of 10
anti-parallel ß-strands apposed by 6 α-helices that define a central cavity whose entrance is
lined by multiple loops (Fig 2A). The TAG glyceryl group is located at this entrance between
loops L1 (aa 65–72) and L2 (aa 95–98). Compared to the position of Ac1PIM2 bound to LprG,
the orientation of TAG is conserved: the hydrophilic glyceryl headgroup interacts with Ser72 at
the cavity entrance. The acyl chains form interactions with the side chains of hydrophobic resi-
dues within the cavity. However, while the three acyl chains of Ac1PIM2 are all bound within
the cavity, only two of the TAG palmitoyl chains (sn1 and sn2) are similarly buried; the third
LprG and Rv1410 Regulate Triacylglyceride Levels and Virulence in Mtb
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acyl chain (sn3) is exposed to the solvent (Fig 2B). The first ten carbons of the sn3 palmitoyl
chain form van der Waals contacts with the hydrophobic sidechains at the cavity entrance,
including Leu95, Leu115, Phe123 and Ile129. Furthermore, the sn3 chain is close to two hydro-
phobic grooves formed by Phe123-Leu115-Ile100 and Leu73-Leu71-Ile68-Val64 (Fig 2B). This
proximity suggests that these grooves could facilitate the binding of TAG with longer acyl
chains.
The lid of the cavity, composed of a helix-loop motif (α2-loop1- α3-loop2), is flexible and
was found in two conformations that define distinct cavity volumes. The volume of the open
form with TAG bound is 1425 Å3 and the closed form is 895 Å3 due to a major inward move-
ment of the cavity lid (aa 129–134). In the closed form, the hydroxyl group on the side chain of
Tyr130 is shifted 4.5 Å toward the center of the cavity, as measured from the hydroxyl oxygen
atom on the side chain. Comparing the helix-loop motif in the closed and open forms, the side
chain of Tyr130 blocks the binding site for the sn2-palmitoyl chain of TAG. Therefore, differ-
ent conformations of this helix-loop motif may help accommodate the binding of diverse
triacylglycerides.
LprG transports triacylglyceride between lipid bilayer membranes
Given the predicted localization of the two proteins, we hypothesized that Rv1410 transports
TAG across the inner membrane and passes it to LprG, which then transfers the lipid to the
outer membrane. Thus, LprG should not only bind to TAG but facilitate movement of TAG
between lipid membranes, analogous to the suggested role of LppX in PDIM localization to the
outer membrane [13]. To test the lipid transfer ability of LprG we used purified proteins in a
vesicle-based assay to measure TAG movement between lipid membranes (S4 Fig) [27]. A pro-
tein-dependent increase in fluorescence indicates the net movement of fluorescently labeled
TAG (dioleoyl-sn3-nitrobenzoxadiazole-C6 glyceride; NBD-TAG) from donor vesicles con-
taining partially quenched NBD-TAG to acceptor vesicles without TAG and thereby demon-
strates whether a protein can both extract TAG from and release it into lipid membranes. We
found that LprG was able to transfer lipids in a protein dose-dependent manner (Fig 2C). Also,
LprG-V91W, a mutant containing a bulky mutation located within the hydrophobic cavity,
transferred TAG at a decreased rate and yield (Fig 2C and 2D) [7]. The marked reduction in
activity is consistent with the reported lower binding affinity of LprG-V91W for triacyl lipids.
In contrast, the LprG homologue LprA had no detectable activity (Fig 2C and 2D), consistent
with our prediction that it cannot bind TAG due to a smaller binding pocket that accommo-
dates only diacylated lipids [7]. Thus, LprG can transfer TAG between lipid membranes, as
predicted from its hypothesized role as a lipid transport protein.
Overexpression of LprG-Rv1410 increases the presence of
triacylglycerides in culture medium ofMtb
Recent data suggest that TAG make up a significant proportion of non-covalently associated
lipids in the outer leaflet of the outer membrane of mycobacteria [18]. If TAG is transported
from the cytoplasm into the cell wall we predicted that it might be shed into culture medium of
Fig 2. LprG binds and transports TAG in vitro. (A) Structure of TAG (48:0) co-crystallized with LprG showing loops L1-L4 that surround the entrance to the
binding cavity. (B) Two hydrophobic grooves (orange) on the surface of LprG and close to the binding site for the sn3-palmitoyl chain may accommodate TAG
with longer acyl chains. (C) Addition of LprG (filled circles) to vesicles with partially self-quenched dye-labeled TAG results in a (C) time-dependent and (D)
protein dose-dependent fluorescence increase. Controls include LprG with a bulky mutation V91W in the binding pocket and the homologue LprA. LprG-
dependent transfer activity is apparent at the first time point (10 min.) due to lag time between reaction initiation and measurement. Data are the average of
three technical replicates and are representative of three independent experiments. Error bars (within data symbols) are +/- SD.
doi:10.1371/journal.ppat.1005351.g002
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broth-grown cultures and be detectable by MS. To test this, we compared the quantities of
TAG in culture medium derived from both mutant and wild- type strains. Lipidomics analysis
of culture medium collected from the WT, Mut2, and Comp2 cells in logarithmic growth
phase revealed low signals for lipids shed into the culture medium with few relative differences
between the strains in both positive and negative mode analysis. In retrospect, this was not sur-
prising given that we were able to detect differences in total cell lipids between strains from sta-
tionary phase, but not log-phase, cultures grown in broth medium. We therefore asked instead
whether overexpression of LprG-Rv1410 would lead to increased quantities of TAG in culture
medium (Fig 3A and S5 Fig). Indeed, we found a greater signal intensity corresponding to
TAG in the culture medium from the overexpression strain (OE) as compared to the
Fig 3. Overexpression of lprG-rv1410c increases TAG released into culture medium of broth-cultured cells. (A) Schematic of the overexpression (OE)
genotype. (B) Comparative lipidomes of culture medium (upper) and total cells (lower) derived from the OE vs. Mut2 strains from log-phase broth-grown cells
(OD 0.7 +/- 0.2). Upper panel, OE vs. Mut2 culture medium (12.5 μg lipid); 2-fold increase, corrected p< 0.05 (red), TAG (yellow overlay). Lower panel, OE vs.
Mut2 total cells (12.5 μg lipid); 2-fold decrease, corrected p< 0.05 (blue), TAG (yellow overlay). Student’s paired t-test (Gene Pattern, Broad Institute of
Harvard, MIT, MGH). (C) Extracted ion chromatogram (EIC) form/z 964.963 (TAG 58:0) in culture medium versus total cell lipid from OE, WT, Mut2, and
Comp2 strains within the sameMS experiment.
doi:10.1371/journal.ppat.1005351.g003
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LprG-Rv1410 mutant (Mut2) (Fig 3B, upper panel). Importantly, OE had increased TAG in
culture medium despite having equivalent to less total cell TAG as compared to Mut2 (Fig 3B,
lower panel). The increased shedding of TAG into culture medium was confirmed using
extracted ion chromatograms that monitor TAG (58:0) ion counts across all genetically altered
andWT mycobacteria (Fig 3C). Furthermore, a trend toward higher normalized TAG signals
in the culture medium of OE was seen for each of the individual TAG alkylforms and the dif-
ference reached statistical significance for many of the alkylforms. This conclusion was further
supported by low detection of the highly abundant inner membrane associated phospholipids,
phosphatidylethanolamine (PE) and cardiolipin (CL), indicating that inner membrane and
cytosolic lipid did not substantially contaminate the filtered cultured medium. Increased TAG
in culture medium of OE is unlikely to be a non-specific effect of overexpression since amounts
of control lipids were not increased in culture medium of OE. The identity of TAG and control
lipids in culture medium was confirmed by MS/MS fragmentation analysis. Similar results
were consistent across two additional experiments that measured TAG accumulation in culture
medium of OE across a range of growth conditions (S6 Fig).
Loss of LprG-Rv1410 function leads to growth attenuation independent
of host immune responses
Complementation of the LprG-Rv1410 operon restores virulence of LprG-Rv1410 mutants in
mice (S7 Fig) demonstrating that the virulence defect is attributable to loss of function at this
specific locus. Previous work suggests that 1) LprG promotes the activation of the innate
immune receptor TLR2 through export of lipoglycans such as PIM and LAM [7,28] and 2)
plays a role in LAM display [8,9]. Both hypotheses attribute the attenuation of the
LprG-Rv1410 mutant in mice to an altered interaction with host immune cells, namely phago-
cytes, leading to enhanced clearance [8,9]. We reasoned that if either immune mechanism
accounted for the strong attenuation seen during infection [29], then loss of innate and
acquired immune functions that occur downstream of both of these processes should rescue
growth of LprG-Rv1410 mutants in vivo.
To examine the role of the innate immune response, we infected nos2-/- and phox-/-mice
that are compromised for oxidative killing mechanisms and neutrophil function, respec-
tively. Oxidative killing by nitric oxide generated by inducible nitric oxide synthase (iNOS;
nos2) in macrophages and neutrophils is a well-documented mechanism forMtb control in
mice [30–32]. Similarly, NADPH oxidase (Phox; phox) is required for reactive oxygen species
(ROS) killing of mycobacteria by neutrophils and macrophages downstream of TLR signal-
ing in response to infection [33,34]. C57/Bl6 wild-type and mutant mice were infected with a
3:1 mixture of Mut1 and the matching H37Rv WT background control. Mut1 was attenuated
in the lung and spleen in all mouse strains, as assessed by colony forming units (cfu) (Fig 4A
and 4B and 4C). Furthermore, loss of generalized oxidative killing also failed to rescue
growth of Mut1 in phox -/-mice administered the iNOS inhibitor aminoguanidine (Fig 4D).
Thus, the attenuation of a mutant lacking Rv1410 activity is independent of these innate
immune control mechanisms.
The onset of the adaptive immune response initiates secondary control mechanisms against
Mtb growth. Specifically, the pro-inflammatory cytokine IFN-γ is critical forMtb infection
control in both mice and humans [35–37]. Importantly,Mtb can downregulate host immune
responses by dampening classical macrophage activation and IFN-γmediated effector func-
tions via TLR2 signaling [38]. If the absence of lipid bound-LprG in LprG-Rv1410 mutants
results in attenuation due to a shift towards classical macrophage activation, then we predicted
that the growth of these mutants should be rescued in ifn-γ -/-mice. We infected ifn-γ -/- mice
LprG and Rv1410 Regulate Triacylglyceride Levels and Virulence in Mtb
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with mixed Mut1 andWTMtb and found that the mutant strain was again attenuated relative
to WT even though three times the infective dose of Mut1 vs. WT was delivered (Fig 4E).
IFN-γ is only one of many effectors that might play a role downstream of adaptive immu-
nity. To more comprehensively test the role of the host adaptive immune response in control-
ling infection with LprG-Rv1410 mutants we used rag-/- or severe combined
immunodeficiency (SCID) mice, which both lack functional B and T lymphocytes. Rag-defi-
cient mice succumbed to disease at 3 weeks post infection with WT bacteria, whereas Mut1-in-
fected mice were still alive at 5 months post infection when the experiment was terminated (Fig
5A). At the end of the experiment, three Mut1-infected mice were moribund with numerous
acid-fast bacilli in their lungs (Fig 5B). This was not specific to the bacterial mutant, the mouse
strain or the route of infection, as SCID mice infected with the Mut2 strain by the low-dose
aerosol route also survived for an extended time (Fig 5C). Thus, the attenuation of the
LprG-Rv1410 mutant is seen in mice with variously altered immune responses (S1 Table),
including innate and downstream adaptive mechanisms that are thought to be relevant to PIM
and LAM action.
Growth ofMtb lacking LprG-Rv1410 is slow during infection
If loss of LprG-Rv1410 interaction with host immunity does not explain lack of growth of
LprG-Rv1410 mutants in vivo, why are these bacteria so markedly attenuated? One clue comes
from longitudinal histopathologic examination of organs harvested from immunocompro-
mised mice infected with LprG-Rv1410 mutants. We sacrificed a subset of Mut2-infected SCID
mice at time points matching the time of death of WT- and Comp2-infected animals. At earlier
time points (60 days) there were few bacteria and little pathologic change in tissues of Mut2-in-
fected lungs, by gross and microscopic pathology (Fig 5D and 5E). Mut2-infected lungs showed
only early evidence of thickening of the alveolar septa due to an influx of macrophages (Fig 5D,
middle and inset). Histiocytic consolidation, suppuration, and necrosis associated with bacte-
rial replication and/or cytotoxic response were not evident in Mut2-infected mice, as seen in
WT and Comp2-infected mouse lungs at the time that mice became moribund (Fig 5D, left
and right). Cfu from the lungs of SCID mice infected with the LprG-Rv1410 mutant were 2
log-fold lower in mice infected with Mut2 at matched time points compared to both WT- and
Comp2-infected mice (Fig 5F). However, after more prolonged infection, bacterial load
increased systemically and the histopathology in Mut2-infected moribund mice was similar to
that seen at early time-points with WT or Comp2Mtb strains at time of death. Cfu from the
spleen of Mut2- infected mice when moribund, although still lower than for WT and Comp2
when moribund, were nearly 1x106. At six months post-infection aggregates of viable and
necrotic macrophages containing numerous acid-fast bacilli were present in the lung, spleen,
heart, and kidney of Mut2-infected SCID mice, consistent with the perimortem changes
described above for WT- and Comp2-infected SCID mice at 50–60 days post-infection (S8
Fig). These results suggest thatMtb lacking LprG-Rv1410 induce the same host reaction as WT
but take longer to accumulate the bacterial mass necessary to induce pathologic changes. Com-
parison of the growth trajectory as measured by cfu over time across the three strains suggests
Mut2 grew more slowly during infection, again pointing away from host response as the major
mechanism by which LprG-Rv1410 affectsMtb virulence.
Fig 4. Rv1410 function is necessary for growth ofMtb in mice with immune deficiencies, indicating that loss of virulence is intrinsic to the
bacterium. Colony forming units (cfu) of WT (H37Rv, black) and rv1410::Tn (Mut1, red) from spleen and lungs of mice infected with a 3:1 (Mut1:WT) mixture.
(A) C57/Bl6 (B) nos2-/- (C) phox-/- (D) phox-/- fed aminoguanidine ad libitum, and (E) inf-γ -/-mice. Cfu were measured in lung and spleen at 1, 7, and 30
days post infection. Error bars showmean +/- SD of three to five animals per time point.
doi:10.1371/journal.ppat.1005351.g004
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Mtb lacking LprG-Rv1410 function grows slowly under in vitro conditions
that mimic infection
Although LprG-Rv1410 mutants grow slowly in the host environment, they exhibit no growth
defect in vitro in standard culture medium (Fig 6A and S2 Table). Furthermore, we were unable
to detect reproducible differences between wild-type and LprG-Rv1410 mutant strains with in
vitro infections of several murine monocytic cell lines. One potential explanation for this
dichotomy is thatMtb utilizes lipids as a carbon source during infection, while glycerol is the
predominant carbon source provided in artificial medium in vitro [39]. Thus, we tested
whether the growth ofMtbmutants would be slower when grown in vitro with lipids as the
sole carbon source. Indeed, Mut2 had a reduced growth rate when cholesterol was the primary
carbon source (Fig 6B and S2 Table). Growth rate attenuation was even more striking on propi-
onate, a toxic byproduct of cholesterol and fatty acid metabolism [40,41] (Fig 6C and 6D and
6E and S2 Table). The growth defect was not reversible with complementation of either LprG
or Rv1410 alone (Fig 6C). Vitamin B12 (VitB12) supplementation also failed to rescue the
growth of Mut2, suggesting that the deficiency is unlikely a result of a defect in the methylma-
lonyl pathway of propionate detoxification (S9 Fig). Therefore, the LprG-Rv1410 mutant dis-
plays an in vitro growth defect when grown on lipids similar to those seen during infection.
Intracellular TAG accumulation suppressesMtb growth
We hypothesized that the growth defect of Mut2 when the carbon source is restricted to lipids
is the result of intracellular TAG accumulation and that blocking TAG transport via the loss of
LprG-Rv1410 function enhances TAG accumulation. If altered levels of intracellular TAG in
LprG-Rv1410 mutants can account for their growth defect in vivo, we predicted altered growth
kinetics of LprG-Rv1410 mutants in vitro due to modified TAG levels. Given the large numbers
of genes encoding both TAG synthases and lipases in mycobacteria [42,43], genetically altering
TAG metabolism proved difficult, so we opted to modulate TAG levels pharmacologically by
inhibiting TAG hydrolysis. We predicted that preventing TAG breakdown would exacerbate
the growth defect of Mut2. Treatment with tetrahydrolipostatin (THL) decreases TAG hydro-
lysis by lipases such as LipY, which is thought to mobilize stored TAG as an energy source dur-
ing the transition out of hypoxia [20]. During growth with cholesterol as the sole carbon
source, THL at 5 μg/ml was bacteriostatic during the first 5 days of culture for all strains tested
(Fig 6B). The growth rate of the WT and Comp2 subsequently recovered and, interestingly,
mirrored the growth rate of Mut2 in the absence of THL. In contrast, the Mut2 treated with
THL did not grow throughout the 7-day culture period.
Conversely, TAG hydrolysis by lipases is thought, via β-oxidation, to provide acetyl Co-A
for both lipid synthesis via FasI and anapleurosis of the TCA cycle [44,45]. Therefore we pre-
dicted that bypassing the need for TAG hydrolysis should at least partially relieve the
LprG-Rv1410-dependent growth defect. To test this, we supplemented the medium with
Fig 5. Attenuation of theMtb LprG-Rv1410mutant in mice persists in the absence of adaptive immunity and is associated with slow growth. (A)
Survival of 28 rag -/-mice infected with either Mut1 (red, n = 14) or WT (black, n = 14) and followed for 5 months. (B) Representative lung section from a
Mut1-infected mouse at end of study (Day 150) with numerous acid-fast mycobacteria, 400x magnification; (inset) multibacillary growth of Mut1 in lung
macrophages, 1000x oil magnification. Ziehl-Neelsen acid-fast with methylene blue counterstain. (C) Survival of 21 SCID mice infected via aerosol with 50–
100 cfu of WT (black, n = 5), Mut2 (red, n = 11), or Comp2 (blue, n = 5) followed for six months. WT- and Comp2-complement infected mice died by 60 days
post-infection. Mut2-infected mice died at 6 months post-infection. (D) Three Mut2- infected mice were sacrificed at the time of death of WT- and Comp2-
infected mice. Hematoxylin and eosin (H&E) stain of lung frommice infected with WT (left), Mut2 (middle) and Comp2 (right) at time of death (WT and
Comp2) or 60 days (Mut2) post-infection, 200x magnification; (inset) small foci of macrophage infiltrate in Mut2-infected lung, 600x magnification. (E)
Formalin- fixed lungs from infected SCID mice. WT (left), Mut2 (middle), Comp2 (left) showing tan nodules on the surface of both WT and Comp2 lungs. (F)
Lung cfu from SCID mice infected with WT, Mut2, or Comp2.
doi:10.1371/journal.ppat.1005351.g005
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acetate, which has been shown to rescue the growth ofMtbmutants with defects in the methyl-
citrate cycle or in cholesterol metabolism when grown in the presence of propionate or choles-
terol, respectively [46,47]. As predicted, acetate partially rescued the growth of Mut2 on
propionate in both minimal and rich medium (Fig 6D and 6E and S2 Table). Similarly, the
addition of glycerol and/or oleic acid rescued growth kinetics of Mut2, which under these con-
ditions were indistinguishable from those of WT and Comp2 strains (Fig 6F and 6G and S2
Table). Furthermore, we determined that the LprG-Rv1410 mutant has decreased susceptibility
to THL in medium supplemented with glycerol and oleic acid (S10 Fig and S1 Methods).
Therefore, although inducing TAG accumulation mimics or exacerbates the loss of
LprG-Rv1410 function, mimicking TAG hydrolysis by supplementing TAG breakdown prod-
ucts such as fatty acids and glycerol has the potential to relieve this stress and restore growth.
Growth rescue by acetate, glycerol, and free fatty acids (FFA) is likely mediated by anapleurosis
of the TCA cycle, but in the context of TAG accumulation, increased levels of these metabolites
may also override inhibitory effects of intracellular TAG by relieving numerous potential nega-
tive feedback mechanisms, on processes ranging from fatty acid synthesis to cell cycle regula-
tion and cell division, that are only beginning to be described in mycobacteria [48–52].
Discussion
Mycobacteria, and Actinomycetes in general, are unique not only in their capacity to synthesize
and store large quantities of TAG, but also in their ability to catabolize TAG as an energy
source during starvation [19,53] [54]. TAG accumulates within lipid droplets in the bacterial
cytoplasm [42,55] and is associated with slow growth and antibiotic tolerance (52). TAG in the
form of lipid droplets provides energy via β-oxidation of the acyl chains [45,56] and TAG
seems to serve a structural role as a major component of the outer leaflet of the outer mem-
brane [18]. Like PDIM, TAG can also serve as a sink to alleviate the accumulation of potentially
toxic propionyl-CoA [46,57]. Here we show loss of LprG and Rv1410 disrupts steady-state lev-
els of intracellular TAG inMtb. This could result in multiple cellular defects, consistent with
the numerous roles that TAG is proposed to play in mycobacterial physiology and metabolism.
Similar to a recent report [58], we show that loss of LprG-Rv1410 results in marked slowing
of growth in vitro whenMtb are restricted to lipid carbon sources, such as cholesterol, that are
likely utilized during infection. Others have shown this gene defect causes immune-activating
defects in vitro, but several lines of evidence suggest that the metabolic defects associated with
LprG-Rv1410 loss play a larger role in growth attenuation in vivo. In the host, lipids represent
the major carbon sources available to the pathogen and these conditions favor TAG production
[59]. We propose that, under such conditions, wild-typeMtb can either transport TAG out of
the cytoplasm into the outer layers of the cell wall or store intracellular TAG, the subsequent
hydrolysis of which generates energy via anapleurosis of the TCA cycle and enables growth
(Fig 7A). Indeed, the growth defect of the LprG-Rv1410 mutant can be titrated by chemical
Fig 6. Carbon restriction slows growth of LprG-Rv1410mutants in vitro and phenocopies slow growth in vivo.WT, Mut2, and Comp2 were cultured in
(A) 7H9 plus ADC (albumin, dextrose, catalase) supplement, 0.2% glycerol, and 0.05% Tween80; (B) Sauton’s minimal medium plus 0.01% cholesterol,
0.05% Tyloxapol and with (dashed) or without (solid) tetrahydrolipostatin (THL; 5 μg/mL); (C) Sauton’s minimal medium, 10mM propionate; (D) 7H9 with
ADC, 0.05% Tween80, 10 mM propionate with (large dashed) or without (solid) 5 mM acetate; (E) Sauton’s minimal medium plus 0.05% Tyloxapol, 10mM
propionate with (large dashed) or without (solid) 5 mM acetate; (F) 7H9 plus ADC, 0.2% glycerol, 10 mM propionate with (large dashed) or without (solid) 5
mM acetate; (G) 7H9 plus ADC with 10 mM propionate, 5 mM acetate, and 0.05% oleic acid (small dashed). (F,G) represent one experiment. Growth was
measured as OD600 at the indicated times. Generation time during exponential growth was estimated from the log-linear slope (S2 Table). Data are the
average of three technical replicates and are representative of three independent experiments. Error bars (within data symbols) are +/- SD. Mut2+ LprG
(ΔlprG-rv1410c L5::lprG); Mut2+ Rv1410 (ΔlprG-rv1410c L5::rv1410c).
doi:10.1371/journal.ppat.1005351.g006
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Fig 7. Model for the role of LprG-Rv1410-mediated TAG transport in regulating the growth rate ofMtb. (A) In the presence of a functional
LprG-Rv1410, FasI makes acyl primers (acyl-CoA) for cell wall lipid synthesis (including TAG via TAG synthases, Tgs). TAG can then be 1) incorporated into
theMtb cell wall via the action of LprG-Rv1410 or 2) hydrolyzed by lipases. Acetyl-CoA for anapleurosis of the TCA cycle is generated via β-oxidation of free
fatty acids (FFA) liberated from TAG. (B) Loss of LprG-Rv1410 function results in increased intracellular TAG due to lack of transport into the cell wall. The
presence of accumulated intracellular TAGmay inhibit growth by a currently unknownmechanism. Decreasing lipolysis via lipase inhibitors further increases
intracellular TAG levels. Addition of acetate, glycerol, or FFA bypasses the need for lipolysis by providing acetyl-coA that feeds into the TCA cycle and
relieves growth arrest.
doi:10.1371/journal.ppat.1005351.g007
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modulation of TAG lipolysis using THL or by providing alternative catabolites, such as acetate
and glycerol. The modulation of the growth defect under such conditions is thus likely a result
of altered metabolism.
In our model cytosolic TAG accumulation restricts bacterial growth and LprG-Rv1410-me-
diated transport of TAG into the cell wall functions as an adjunct to lipases to eliminate cyto-
solic TAG. In mycobacteria stresses such as acidic pH, carbon restriction, acid stress and
hypoxia induce shifts in central carbon and lipid metabolism inMtb that lead to intracellular
TAG accumulation [4,19,42,44]. Under these conditions there has typically been an association
of intracellular TAG with an altered growth state. We present a model by which TAG may
chemically or physically participate in growth regulation during the carbon restriction experi-
enced in the host. One possibility is that cytosolic TAG levels in mycobacteria contribute to
negative feedback mechanisms known to regulate lipid metabolism in other bacterial species.
For example, FFA act as regulatory molecules in E.coli lipid biosynthesis [60] and recent data
suggest that FFA regulate lipid synthesis by regulating fatty acid synthase (FasI) in both myco-
bacteria and corynebacteria [48,61,62]. FFA have also recently been shown to bind transcrip-
tion factors that regulate the MmpL family of transporters, some of which transport specific
classes of outer membrane lipids and are also associated with lipid biosynthesis [63]. If FFA
released by TAG hydrolysis act in a similar fashion, TAG transport out of the cytosol and into
the outer membrane could allow for sequestration of these lipids as a means to regulate central
carbon and lipid metabolism in mycobacteria.
One alternative explanation for our findings is that loss of LprG-Rv1410 results in increased
TAG production. However, increased TAG production occurs normally during the course of
wild-typeMtb infection, as seen with lipid body formation, and is therefore unlikely to account
for the attenuation of LprG-Rv1410 mutants in mice. The model presented here suggests that
TAG transport by LprG-Rv1410 is critical under conditions that favor increased TAG produc-
tion and storage during cellular stress. During growth resuscitation after hypoxic stress, intra-
cellular stores of TAG are hydrolyzed, providing acetyl-CoA to fuel the TCA cycle. A similar
dynamic likely occurs during carbon restriction. We propose that titration of growth in
response to carbon restriction is partly a function of intracellular TAG levels and that these lev-
els are modulated by TAG export and/or hydrolysis. In the background of LprG-Rv1410 loss,
this balance is shifted towards TAG accumulation and therefore bacterial growth arrest is sus-
tained (Fig 7B). It has been proposed that one way in which mycobacteria can co-catabolize
multiple carbon sources is by segregating lipid catabolism into different compartments within
the cell, including the periplasmic space [64]. One possibility is that TAG transport by
LprG-Rv1410 contributes to carbon source segregation in mycobacteria. Our model can
account for the attenuation and slow growth rate seen with the LprG-Rv1410 mutant in SCID
mice and the overall lack of growth rescue irrespective of host immune status.
In this study we set out to uncover the mechanism responsible for the in vivo attenuation
reported for both LprG and Rv1410 mutants in mice [5]. To date, much of the data on the role
of the lprG-rv1410c operon has centered on LprG, an experimentally more accessible molecule.
For the phenotypes we have tested inMycobacterium tuberculosis andMycobacterium smegma-
tis [12], LprG mutants essentially phenocopy Rv1410 mutants, suggesting that these proteins
act in concert to perform an essential function during growth within the host. Here we report
that LprG binds TAG and is capable of mediating lipid transfer between vesicles. Thus, it
appears likely that Rv1410 is responsible for the transport of TAG across the cytosolic mem-
brane, allowing LprG to access TAG, although we cannot measure this directly. This model
predicts that mislocalization of TAG would contribute to the increased levels detected in
LprG-Rv1410 mutants. Our studies evaluating TAG released into culture medium show that
overexpression of LprG-Rv1410 increases the presence of TAG, further supporting our
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hypothesis that TAG is a quantitatively significant substrate of the LprG-Rv1410 transport
system.
Is TAG transport the only role for the LprG-Rv1410 system? Other reports show that vari-
ous lipids can bind to LprG in vitro and that cells that lack this transporter system display
reduced levels of surface LAM [8,9]. TAG, PIM and LAM are triacylated lipids that are all
proven to bind and occupy the large cavity of LprG, suggesting that the system operates to con-
trol the localization of triacylated lipids. [8,9]. However, upon disruption of the LprG-Rv1410
locus, steady-state quantities of TAG change more than 50-fold, which is much greater than
the changes observed for the immunogenic phospholipids PIM and LAM. Demonstration of
differential localization of TAG within the cell wall will be necessary to confirm our model that
LprG-Rv1410 physically transports TAG. Nevertheless, our data suggest that the conditional
essentiality of the lprG-rv1410c operon in vivo is a direct consequence of its non-redundant
role in modulating intracellular TAG and, thereby, lipid metabolism and growth regulation.
TAG storage has long been a defining feature of mycobacterial infection. TAG inMtb has
served primarily as a marker for stationary, dormant, or latent states, all of which have implica-
tions for drug effectiveness, drug resistance, and disease progression. Yet, we have only rudi-
mentary knowledge about how TAG contributes to the processes leading to these states and
overall cellular metabolism at the host-pathogen interface, an understanding of which is critical
to the development of new preventive and therapeutic approaches to infection control. We
propose that TAG transport critically regulates intracellular TAG levels during certain growth
states within the host [19,42,55,65]. Certainly, lipid metabolism is central to growth regulation
in mycobacteria. Our model suggests that synthesis, transport, and hydrolysis of TAG are bal-
anced in a manner that regulates growth rate, assigning a far more complex role for TAG in
Mtb cellular homeostasis than has been previously suggested. Clearly, though, regulation is
more than just abundance, and future studies will need to evaluate the subcellular distribution
of TAG and other lipid mediators in order to determine their collective roles in lipid homeosta-
sis and potential growth regulation.
Materials and Methods
Ethics statement
The Harvard Medical School (HMS) IACUC approved the animal care and use protocol
03000. The HMS IACUC adheres to the Public Health Service Policy and Animal Welfare Act.
Culture of mycobacteria
The virulent H37Rv strain ofMtb was used for all experiments unless otherwise noted. Cells
were routinely cultured in Middlebrook 7H9 broth and supplemented with 10% (vol/vol)
OADC (Middlebrook), 0.2% glycerol, and 0.05% Tween 80. For cells destined for lipidomics
analysis, Tween-free media was used. Cells were maintained at 37°C with shaking at 100rpm.
Lipid extraction, normalization, and high performance liquid
chromatography mass spectrometry
Lipids were extracted and analyzed as previously described fromMtb during either logarithmic
growth phase in 7H9 liquid medium (O.D. 0.8 +/- 0.1) or stationary growth phase from 7H9
agar plates (1.5% w/v Bacto-Agar) [21]. For extraction of lipids from culture medium, approxi-
mately 50 mL of culture medium obtained after centrifugation ofMtb grown in Tween-free
medium was filtered twice with 1 μm average pore-size filters (Millipore). Lipids were extracted
by addition of 6 N HCl (0.3% final v/v) followed by addition of 140% v/v ethyl acetate for 30
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minutes with gentle rocking. Extracts were centrifuged and the upper organic phase collected,
pooled, and evaporated to dryness using a Genevac system (SP Scientific). Lipid masses per
sample were measured and dried lipids were resuspended to 1mg/mL in 1:1 chloroform: meth-
anol. 5 μg to 20 μg of total lipid per technical and biological run were injected for HPLC/MS
analyses. Sample titration was necessary to determine sample load for optimal detection and
quantitation of TAG using normal phase chromatography. Lipids events were detected and
defined as previously described using positive mode HPLC/MS [21], and lipidomes were ana-
lyzed using XCMS algorithm in R (Scripps) and GenePattern Software (Broad Institute). See
also supplemental experimental procedures.
Triacylglyceride transfer assay
C-terminally 6xHis-tagged recombinant proteins were cloned, overexpressed, and purified
largely as described (Suppl Experimental Methods) [28]. TAG transfer assays were performed
as previously described [27]. Briefly, donor vesicles containing 450 nmol/mL phosphatidylcho-
line (PC) and 14 nmol/mL of fluorescently labeled NBD-TAG (dioleoyl-sn3-nitrobenzoxadia-
zole-C6 glyceride, custom synthesis by Avanti Polar Lipids) were mixed 1:1 with acceptor
vesicles containing 2400 nmol/mL of PC either with or without LprG, LprG-V91W
(LprG-VW), or LprA and buffer for a final volume of 100 μL. Plates were incubated at 37°C
and fluorescence was monitored as a function of time with a 7620 Microplate Fluorometer
(Cambridge Technology, Watertown, MA) using 460-nm excitation and 530-nm emission.
The fluorescence representing the total TAG content of donor vesicles was determined by dis-
rupting donor vesicles with isopropanol and measuring the final fluorescence. Percent TAG
transfer was determined by subtracting the no-protein control and dividing by total TAG con-
tent [27]. See also supplemental experimental methods and S4 Fig.
Co-crystallization with triacylglyceride
Purified LprG was produced as described previously [7]. Prior to the crystallization, a three-
molar excess of powdered tripalmitoyl glyceride (TAG) was directly added to LprG. The mix-
ture was incubated on ice for 1 h. Crystals were grown in 0.1 M sodium acetate buffer pH 4.5
with 25% (w/v) PEG3350. Data were collected to a resolution of 1.8 Å at the Argonne National
Lab (beamline 23-ID). Processed with HKL2000, the space group was C2 and cell dimensions
were a = 95.7 Å, b = 71.6 Å, c = 61.8 Å, α = 90°, β = 106.6°, γ = 90°. Structural solution was
obtained by MOLREP, using the apo-LprG structure (PDB: 3MH8) as an initial model. The
structure was built and refined with coot, CCP4 and PHENIX. The final R-work and R-free
were 20.4% and 23.4%, respectively.
Mouse infections
Six- to eight-week-old mice were purchased from The Jackson Laboratory (Bar Harbor, ME).
The various mouse strains and their relevant immunological characteristics are shown in S1
Table. Mice were housed under sterile conditions in an ABSL3 facility, and all animal experi-
ments were performed under an animal protocol approved by Harvard University. Mycobacte-
rial strains were grown in 7H9 with OADC (Middlebrook), 0.2% glycerol and Tween 80.
Approximately 1x106 cfu were administered for IV infections. All strains used for mouse infec-
tions (WT, Mut1, Mut2, Comp2) were confirmed PDIM positive by TLC. For aerosol infec-
tions cells in log-phase growth were sonicated and diluted 1:100 in PBS, and approximately
100–300 cfu administered. For competition experiments the mutant Rv1410::Tn (Mut1), and
wild- type, H37Rv (WT), strains were mixed at a ratio of 3:1 (Mut1:WT). WT is unmarked and
Mut1 is kanamycin-resistant. For all experiments, spleens and lungs were harvested and plated
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for cfu on 7H10 agar or Middlebrook 7H9+1.5% Bacto Agar (Difco) containing OADC enrich-
ment (Middlebrook) and 0.2% glycerol with and without kanamycin (25 μg/mL). Three to five
mice per group were harvested at the indicated time points. A subset of phox-/- received the
reagent aminoguanidine (AG) ad lib. For survival of rag-/-mice, 14 mice per group were
infected with WT or Mut1 and followed out to five months. For survival of SCID mice, double
lprG-rv1410c knockout (Mut2) and complement strains (Comp2) were generated as described
(S1 Fig and S1 Methods). Five mice per group were infected by aerosol and followed for 6
months. An additional 10 SCID mice were infected with Mut2 and followed longitudinally
with matched sacrifices at time of death of WT infected mice and Comp2-infected mice. At
time of death complete necropsy, histopathological evaluation, and cfu enumeration from lung
and spleen homogenates were performed. See also supplemental experimental methods.
Carbon restriction
Mycobacteria were cultured as described above. For carbon restriction, Sauton’s minimal
media containing 0.5 g/L asparagine, 1.0 g/L KH2PO4, 2.5 g/L Na2HPO4, 50 mg/L ferric ammo-
nium citrate, 0.05g/L MgSO4•7H20, 0.05 g/L CaCl2, 0.01 mg/L ZnSO4 and 0.05% Tyloxapol
(vol/vol) was used with addition of either cholesterol (0.01% w/v) or propionate (10 mM) with
or without supplementation with acetate (5 mM), glycerol (0.2% v/v), or both, as indicated.
Cholesterol-containing media was prepared from 500x stocks made by dissolving cholesterol
in 50:50 ethanol/Tyloxapol.
Supporting Information
S1 Methods. Supplementary Methods includes further information on 1) Genetic Manipu-
lation ofMtb, 2) Data processing, quantitative data analysis and statistical analysis using R
and Gene Pattern, 3) Cloning and expression of lipoprotein expression vectors, and purifi-
cation of His6-tagged lipoproteins, 4) Determination of MIC for tetrahydrolipostatin, and
5) Histopathologic analysis of mouse tissue.
(PDF)
S1 Fig. (Related to Fig 1 and S1 Methods) Genetic manipulation ofMtb to generate
LprG-Rv1410 double knockout. The cosmid 2_33 containing the lprG-rv1410c genes was
used as a template to amplify a linear PCR product (ajm2F, ajm2R) with 50 basepair (bp)
homology upstream and down stream of the operon flanking a chloramphenicol/hygromycin
(Chlor/Hyg) resistance cassette. Step (1) Recombineering was performed in the E.coli pkD119
strain containing a lambda-red recombinase plasmid to exchange the Chlor/Hyg cassette with
the lprG-rv1410c genetic locus on the 2_33 cosmid. Step (2) the recombinant cosmid is used as
a template to generate a linear PCR product (ajm3F, ajm3R) with 500 bp chromosomal homol-
ogy upstream and downstream of the lprG-rv1410c operon (replaced by Chlor/Hyg). Step (3)
the 3kb linear PCR product is transformed into confirmed PDIM positiveMtb (H37Rv) previ-
ously transformed with pRecET, expressing the mycobacterial che9 phage recombinase under
control of an isovaleronitrile inducible promoter (pNIT). Step (4), successful recombination
results in a chromosomal deletion of lprG-rv1410c with replacement by the chloramphenicol/
hygromycin cassette. The recombinase plasmid is cured by counter-selection on 10% sucrose.
(PDF)
S2 Fig. (Related to Fig 1) Confirmation of TAG identity by collision induced dissociation
(CID) mass spectrometry. Lipid extract fromMut2 was prepared for collisional MS as
described in Materials and Methods. (A) CID form/z 964.93 (TAG 58:0) in Fig 1C. (B) CID for
m/z 824.77 (TAG 48:0) and deduced fragmentation showing observed diacylglyceride units
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(m/z 703.66 andm/z 551.50). (C) CID form/z 976.72 (TAG 59:1) and deduced fragmentation
showing observed diacylglyceride units (m/z 551.50).
(PDF)
S3 Fig. (Related to Fig 1) Levels of selected lipids in the mycobacterial lipidome across
strains as detected by HPLC/MS. Lipid extract from the indicated strains (Fig 1A) was puri-
fied and analyzed as described in the Materials and Methods and S1 Methods. (A) Relative
intensity of non-TAG lipids detected in Mut1, Mut2, and WTmycobacteria. (B) Relative
intensity of non-TAG lipids detected in Comp2, Mut2, and WTmycobacteria. Two-way
ANOVA with Bonferroni post-test (Mut1, Mut2 vs. WT) and (Comp2, WT vs. Mut2),
 p< 0.05,  p< 0.01,  p<0.001. Cardiolipin, CL (m/z 1423.04); monoacylated phosphati-
dyl-myo-inositol dimannoside, PIM1Ac2 (m/z 1451.91); phosphatidylethanolamine, PE (m/z
734.57); diacylglycerol, DAG (m/z 612.55); phosphatidylglycerol, PG (m/z 766.55); phosphati-
dylinositol, PI (m/z 870.60); diacyltrehalose, DAT (m/z 976.76); trehalose monomycolate,
TMM (m/z 1595.43).
(PDF)
S4 Fig. (Related to Fig 2) A schematic for the vesicle-based assay used to measure TAG
transfer activity. Donor vesicles contain a concentration of NBD fluorophore-labeled TAG
that results in partial self-quenching of the NBD fluorescence. In the presence of excess accep-
tor vesicles, which lack NBD-TAG, LprG extracts and binds NBD-TAG from acceptor vesicles
and deposits it into donor vesicles. This activity is observed as an increase in fluorescence.
(PDF)
S5 Fig. (Related to Fig 3) Western blot for native LprG shows overexpression of the
LprG-Rv1410 operon.Mtb lysates were prepared from late logarithmic phase cells in standard
7H9 media (OADC, 0.2%glycerol, 0.05% Tween 80) then baked at 80°C for 2 hours in SDS Lae-
melli buffer. Culture medium was filtered twice (0.2 micron, Millipore). Protein concentration
was determined for cell lysates using a non-interfering (NI) protein assay (Biosciences). Lane 1:
H37Rv (WT, 12 μg/μL); Lane 2 WT culture medium; Lane 3: ΔlprG-rv1410c (Mut2, 12μg/μL);
Lane 4: Mut2 culture medium; Lane 5: ΔlprG-rv1410c L5::lprG-rv1410c (Comp2, 12.5 μg/μL);
Lane 6: Comp2 culture medium; Lane 7: WT L5::lprG-rv1410c (OE, 10.6 μg/μL). Lane 8: OE
culture medium. Equal loading by volume for all lanes. Primary mouse monoclonal anti-LprG
1:100 (US Biologics); secondary goat anti-mouse HRP 1:10,000.
(PDF)
S6 Fig. (Related to Fig 3) TAG counts increase in culture medium with overexpression of
LprG-Rv1410 over a range of experimental conditions. A) Counts of TAG events from 5 μg
of culture medium lipid normalized to 10,000 matching TAG events in 2.5 μg of total cell lipids
within a single MS analysis (OD 0.8 +/- 0.2) from OE, WT, Mut2, and Comp2 strains. B) Nor-
malized ion counts for control lipids detected in culture medium from (A). PDIM (m/z
1385.43), diacylglycerol, DAG (m/z 612.55), monoacylated phosphatidyl-myo-inositol diman-
noside, PIM1Ac2 (m/z 1451.91), cardiolipin, CL (m/z 1423.04), phosphatidylethanolamine, PE
(m/z 734.57). C) Counts of TAG events in 10μg culture medium normalized to 100,000 match-
ing TAG events in 5 μg total cell lipid (OD 0.7 +/- 0.2) from OE, WT, Mut2, and Comp2
strains. (A,B,C) OE vs. WT ‡, OE vs. Mut2 †, OE vs. Comp2  p<0.05,  p<0.01, p<0.001;
2-way ANOVA with Bonferroni post-test correction. D) Counts of all TAG events (48:0–60:0)
from 10 μg culture medium normalized to 100,000 matching TAG events in 5 μg total cell lipid
from cultures harvested over three consecutive days: late log (OD 0.5–0.9), early stationary
(OD 1.0–1.2), and late stationary (OD 1.5–2.0). OE vs. WT ‡, OE vs. Mut2 †, OE vs. Comp2
 p<0.05,  p<0.01, p<0.001. One-way ANOVA with Bonferroni post-test correction.
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TAG on average is higher in culture medium with overexpression but decreases over time (D).
Normalization was performed to account for the indicated variation in OD at time of collection.
(PDF)
S7 Fig. (Related to Figs 4 and 5) Complementation of LprG-Rv1410 operon restores viru-
lence in C57/Bl6 mice. A) Composite graph of cfu recovered from the lungs of mice in two
competition experiments: Mut1:WT (3:1) and Comp1:WT (3:1), as performed in Materials
and Methods. B) Cfu recovered from the spleens of mice (five per group) receiving single strain
IV tail vein infections with 1x106 cfu of WT, Mut1, or Comp1. Cfu = colony-forming units.
Mut1 = mutant 1, WT = wild-type (Fig 1A), Comp1 = rv1410c::Tn + pMV762 lprG-rv1410c.
(PDF)
S8 Fig. (Related to Fig 5) Mut2 infected SCID mice show comparable gross and micro-
scopic pathological change to WT and Comp2 infected mice at time of death. SCID mice
were infected by aerosol with 50 colony-forming units (cfu) of WT, Mut2, or Comp2 (Fig 1A)
as described in the Materials and Methods. A) Gross images of formalin-fixed heart, spleen,
lung, and kidney from a representative Mut2- infected SCID mouse at termination of survival
experiment. Tan lesions viewed macroscopically represent macrophage and bacteria filled
aggregates. One such lesion in the lung highlighted with a red box corresponds to histopathol-
ogy as seen in (B). B) Microscopic image of formalin-fixed, paraffin embedded lung showing
macrophage aggregates containing numerous acid-fast bacilli (upper, 200x magnification;
inset, 600x magnification). Ziehl-Neelsen acid fast staining with methylene blue counterstain.
On average 2x106 cfu were recovered fromMut2 infected SCID lungs at 6 months post-infec-
tion. C) Spleen colony-forming units (cfu) recovered fromWT, Mut2, and Comp2 infected
SCID mice at time of sacrifice/death. Mut2 infected spleens contained on average 2.25x106 cfu.
(PDF)
S9 Fig. (Related to Fig 6) Vitamin B12 supplementation does not rescue growth defect of
LprG-Rv1410 mutant in propionate. The indicated strains were cultured in 10 mM propio-
nate as described in the materials and methods with or without the addition of +/- 0.5 μg/mL
vitamin B12 (VitB12; dashed lines) at 37°C with shaking. Growth measured by OD 600, mean
+/- standard deviation.
(PDF)
S10 Fig. (Related to Fig 6) Addition of glycerol decreases susceptibility of the LprG-Rv1410
mutant to tetrahydrolipostatin.MIC was determined as described in the Supplementary
Materials and Methods. The MIC for WT, Mut2, and Comp2 was 62.5–125μg/mL in 7H9
+ OADC (Sigma).
(PDF)
S1 Table. (Related to Figs 4 and 5) Mouse strains used for competition and survival experi-
ments.
(PDF)
S2 Table. (Related to Fig 6) Effect of Carbon source restriction of growth rate ofMtb in
vitro.
(PDF)
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